A Randomized Study of SPK-10001 Gene Therapy in Participants With Huntington's Disease
Phase 1/2 study testing SPK-10001 in Huntington's disease.
RecruitingPhase 1 / Phase 2GeneticClinicalTrials.govTreatment trial
Recruiting in: Boston, Cincinnati, Columbus +2 more, United States
Sponsor: Hoffmann-La Roche
Preparing a short plain-English summary.